Wan Renjie – Trademark Portfolio
Entity Type: 01
Wan Renjie owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ADEVIT, BEEPOW, APTEDEX, and SEAPLENN. Of these, 5 are registered. The portfolio spans 4 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 1 (Chemicals). Headquartered in Jiangxi.
2, 138 Wancun Natural Village, Luojia To
Qingshanhu District, Nanchang
Jiangxi 330012 , CN
Showing of trademarks Trademarks
Trademark Classifications
Wan Renjie's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Wan Renjie have?
Wan Renjie has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Wan Renjie file in?
Wan Renjie files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 11 (Environmental Control), Class 28 (Toys & Sporting Goods). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Wan Renjie's most well-known trademarks?
Wan Renjie's registered trademark portfolio includes well-known marks such as ADEVIT, BEEPOW, APTEDEX, and SEAPLENN. These are among 5 currently registered trademarks in the portfolio.
What is Wan Renjie's trademark registration success rate?
Wan Renjie has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.